VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds

Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
You are here: IndiaNotes

Filter search : Quote Research All

Reports for search string : estimation

A Complete Guide in Planning Your Monthly Budget
B-U-D-G-E-T Ö what does this six letter word mean to you? Cutting down costs? Knowing where to spend and where not to? An exercise to remind yourself to stay within your means? Do you have a monthly b...
elearnmarkets, 20 Jul 2017
French Showers Gratify Global Stock Markets
'Better than expected' is going to be the most used term by analysts in the coming few months. Ultratech, HDFC Bank, Indian Bank, Wipro and Reliance Industries should thank these pessimistic pragmatic...
Suhani Adilabadkar, 27 Apr 2017
Indian equity benchmarks trade on lackluster note
Indian equity benchmarks traded on lackluster note and ended the session in red with cut of around one and quarter percent. Nifty closed below 8100 mark.
Jainam Research, 02 Dec 2016
Trumping Black Money
On November 8, the US elected Donald Trump, and our government decided to trump black money. The move to discontinue the higher denomination notes in circulation is bold. However, boldness is not a vi...
Ajay Shah, 14 Nov 2016
Five sectors that have grown like a youth in September
Dynamic Levels are researching five sectors that have grown like a youth in the month of September 2016. They are also commenting on preferred stocks in these five sectors. They are ultimately advisin...
Dynamic Equities Pvt Ltd, 22 Sep 2016
Sun Pharmaceutical 4QFY16: Core sales in line; EBITDA, PAT rise above estimation
Sun Pharma reported sales of Rs 74bn (up 21.5% YoY) with an EBITDA of Rs 23bn (EBITDA margin 31%) and PAT of 17bn in Q4FY16. Adjusting with exclusivity sales of Gleevec, integration of opiod API sales...
Prabhudas Lilladher, 01 Jun 2016
Motivations for capital controls and their effectiveness
The global financial crisis has re-opened the debate on the place of capital controls in the policy toolkit of emerging-market economies (EMEs). The volatility of capital flows during and after the gl...
Ajay Shah, 14 Apr 2016
New Lending rate regime from April 2016, smooth transition led by dual structure
RBI introduced dual rate regime in the final guidelines for the smooth transition from Base Rate to Marginal Cost of Funds based Lending Rate (MCLR). At the system level, we see this as largely Neutra...
Motilal Oswal, 18 Dec 2015
Third Quarter Results: Buy NTPC at CMP and add on dips
During Q3FY15, NTPC reported Net Sales of Rs 18739 cr flat on y-o-y but up 13% q-o-q while Reported PAT was up 7.4% y-o-y to Rs 3074 cr. Operating margins were flat on y-o-y basis at 24.7% in Q3FY15 ...
HDFC Sec, 04 Feb 2015
The imprecision of volatility indexes
A remarkable feature of options trading is that it reveals a forward-looking measure of the market's view of future volatility. This was first done by CBOE in 1993 with the S&P 500 index options, with...
Ajay Shah, 19 Nov 2014
Bank of Baroda Q2FY15: NIM steady at 2.4%, buy & add on dips
Global NIMs of BOB have remained stable at 2.4% in Q2FY15 compared to 2.32% in Q2FY14 and 2.35% in Q1FY15. Domestic NIMs have improved to 3.02% in Q2FY15 from 2.85% in Q2FY14 and 2.94% in Q1FY15. Buy ...
HDFC Sec, 14 Nov 2014
Lupin Results Update: Buy for a target of 1545
Lupin underperformed in terms of sales, while outperformed in terms of earnings with respect to our estimation for the quarter. Revenue was lower than our estimates primarily due to lower than expecte...
IndiaNivesh, 29 Oct 2014
Jubilant Life Sciences: Revival in PPES shows positive trend, buy
Jubilant Lifeís sales increased by 12% to Rs15.5bn in Q4FY14, in line with our estimation. Higher volume and improvement in price environment of Nutritional products were prime contributors in rise in...
Prabhudas Lilladher, 27 May 2014
How will the economy evolve and stock markets react if Congress forms a coalition government?
Over the last few weeks have been trying to look at probable economic outcomes and stock market scenarios given different possible political outcomes after the 2014 General Election...., 15 May 2014
Lupin's Q4FY14E sales likely to achieve 25% y-o-y growth; Ranbaxy expected to post sales of 11% y-o-y
Prabhudas Lilladher expect Lupinís Q4FY14E sales to achieve 25% y-o-y growth. They expect sales of 11% y-o-y (in Rupee terms) for Ranbaxy Laboratories while decline 4% q-o-q due to loss of exclusivity...
Prabhudas Lilladher, 21 Apr 2014
Fixing MIBOR: Comments on the draft report of the RBI committee on financial benchmarks
LIBOR is made by asking a few dealers what the price on the market is. The LIBOR scandal involves allegations that dealers in London made up the numbers.
Ajay Shah, 20 Jan 2014
Earning's Preview: Accumulate Lupin and Ranbaxy
Prabhudas Lilladher expect Lupin's Q3FY14E sales to achieve 15% y-o-y growth, while for Ranbaxy they expect sales of 2% y-o-y (in Rs terms) while decline 12% q-o-q due to exclusivity of Actos and Cadu...
Prabhudas Lilladher, 15 Jan 2014
Jubilant revenues to grow at 13% YoY; Lupin sales to achieve 20% YoY growth
Prabhudas Lilladher expect Jubilant Life's Q2FY14E revenues to grow at 13% YoY to Rs14bn, led by the US and EU generics and APIs. They expect Lupin's Q2FY14E core sales to achieve 20% YoY growth on th...
Prabhudas Lilladher, 15 Oct 2013
Food security bill passed in Lok Sabha, fiscal and inflation risks overplayed
The Lok Sabha passed through the National Food Security Bill. The key provision of the bill is, it covers two third of the population under defined entitlement of 5kg of cereals per person per month f...
Motilal Oswal, 29 Aug 2013
Lupin Q1FY14: Withdrawal of drugs impact India sales
Lupin's core sales (adjusted hedge loss) of Rs24.9bn increased by 12% vis-a-vis their estimate of Rs25.9bn on the back of withdrawal of three brands in India, fall in Japan sales and USD 0.5m Antara s...
Prabhudas Lilladher, 13 Aug 2013
View All

Intraday Tips

What are technical calls?
* SEBI certified analyst

View Stock Advice by: